FAIR VALUE MEASUREMENTS (Details Textual) (USD $)				1 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2011	Mar. 31, 2010 Manhattan and Ariston Pharmaceuticals Merger [Member]
Fair Value Measurement [Line Items]
Notes Issued				$ 15,452,793
Debt Instrument, Interest Rate, Effective Percentage	5.00%	5.00%		5.00%
Debt Instrument, Convertible, Conversion Price				$ 1,125
Percentage Of Cash Proceeds From Operation To Repay Convertible Debt				50.00%
Long-term Debt, Gross	19,310,000	18,614,000	16,876,000
Debt Instrument, Fair Value Disclosure			$ 3,287,700
Debt Instrument, Term				5 years